Medtronic launches fourth generation flow diverter to treat brain aneurysms
01 June 2022 | News
The new flow diverter with enhanced design features for both the delivery system and implant
India Medtronic has launched CE marked fourth-generation flow diverter, Pipeline Vantage with Shield Technology for endovascular treatment of brain aneurysms. Pipeline Vantage with Shield Technology is a new flow diverter with enhanced design features for both the delivery system and implant. These features allow physicians to deliver, deploy and treat brain aneurysms and intracranial aneurysms with greater ease and reliability while providing a scaffold that promotes the growth of cells in the inner lining of the target blood vessel.
Medtronic is also introducing a first-of-its-kind warranty programme called the PED Warranty Program. Through the warranty programme, patients treated with Medtronic’s Pipeline Embolization Device (Pipeline Flex Embolization Device with Shield Technology/ Pipeline™ Vantage with Shield Technology) will receive warranty coverage.
